SEC Tracker
Get the app

Microbot Medical MBOT

Microbot Medical reported a net loss of $13.14 million for 2025.

Proxy statement

Form
DEF 14A
Filed
Importance
Routine
  1. Net loss: $13.14 million for the year ended Dec 31, 2025.
  2. Annual meeting scheduled for Dec 14, 2026.
  3. Election of two Class II directors proposed.
  4. Amendment to 2020 Omnibus Performance Award Plan to add 1,000,000 shares.

Written from the DEF 14A on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Microbot Medical files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Fonar FONR
  2. Pulmonx LUNG public float $101M, Jun 30, 2025
  3. Accuray ARAY public float $87M, Dec 31, 2025
  4. Lucid Diagnostics LUCD public float $83M, Jun 30, 2025
  5. TriSalus Life Sciences TLSI public float $112M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.